Alyea Therapeutics is pioneering investigational next-generation, non-opioid treatments that go beyond masking pain–we target its root cause to deliver lasting relief without addiction risks.
Leading institutions have studied Low Dose Naltrexone (LDN) as a breakthrough non-opioid pain treatment with strong safety and efficacy data.
Alyea is advancing investigational next-generation, non-opioid solutions designed to provide effective, lasting relief—without the risks of addiction.
An investigational next-generation, non-opioid treatment, LDN targets inflammation and pain pathways to provide lasting relief without addiction risks.
Learn More
A next-generation topical pain relief technology, designed for targeted, non-invasive treatment with strong market potential.
Learn More
Alyea is led by world-class pain specialists dedicated to replacing opioids with safer alternatives. With research and decades of experience, we’re pioneering a new standard in pain management. Our expertise ensures patients get real relief—without the risks of addiction.
